Uridoki (418A) Announces Q1 FY2026 Financial Results: Net Sales of JPY 545 Million, Operating Income of JPY 103 Million

Uridoki has announced its financial results for the first quarter of the fiscal year ending February 2026 (March 1, 2025 - May 31, 2025).

Uridoki reported net sales of JPY 545 million for the quarter. Operating income reached JPY 103 million, and ordinary income was also JPY 103 million. Profit before tax stood at JPY 103.759 million, with net income at JPY 71.729 million. Earnings per share (EPS) for the period was JPY 16.74.

Regarding profitability, Uridoki reported an operating profit margin of approximately 18.89% and a net profit margin of approximately 13.16% against net sales, which are strong levels. The return on equity (ROE) was 14.93%, and return on assets (ROA) was 9.23%, suggesting efficient capital utilization and asset management.

From a financial health perspective, Uridoki's equity ratio is 61.8%, a healthy level. Interest-bearing debt is JPY 19.106 million, which is low relative to its total assets.

In terms of market valuation, the current stock price implies a Price-to-Earnings Ratio (PER) of 54.06x, a Price-to-Book Ratio (PBR) of 8.07x, and a Price-to-Sales Ratio (PSR) of 7.12x. These valuation metrics may reflect the market's high expectations for Uridoki's future growth. Investors will likely continue to monitor how future performance aligns with these expectations.

It should be noted that year-on-year growth rates, progress against full-year forecasts, and multi-year CAGR growth trends cannot be confirmed from the provided data.